Linc00941 is a novel transforming growth factor β target that primes papillary thyroid cancer metastatic behavior by regulating the expression of cadherin 6
M Gugnoni, V Manicardi, F Torricelli, E Sauta… - Thyroid, 2021 - liebertpub.com
Background: Papillary thyroid cancers (PTCs) are common, usually indolent malignancies.
Still, a small but significant percentage of patients have aggressive tumors and develop …
Still, a small but significant percentage of patients have aggressive tumors and develop …
Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6.
M Gugnoni, V Manicardi, F Torricelli, E Sauta… - …, 2021 - search.ebscohost.com
Abstract Background: Papillary thyroid cancers (PTCs) are common, usually indolent
malignancies. Still, a small but significant percentage of patients have aggressive tumors …
malignancies. Still, a small but significant percentage of patients have aggressive tumors …
[引用][C] Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin …
M Gugnoni, V Manicardi, F Torricelli, E Sauta… - Thyroid, 2021 - cir.nii.ac.jp
Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid
Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6 | CiNii Research CiNii …
Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6 | CiNii Research CiNii …
Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6.
M Gugnoni, V Manicardi, F Torricelli… - … : Official Journal of the …, 2020 - europepmc.org
Background: Papillary thyroid cancers (PTCs) are common, usually indolent malignancies.
Still, a small but significant percentage of patients have aggressive tumors and develop …
Still, a small but significant percentage of patients have aggressive tumors and develop …
Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6
M Gugnoni, V Manicardi, F Torricelli… - … : official journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background: Papillary thyroid cancers (PTCs) are common, usually indolent malignancies.
Still, a small but significant percentage of patients have aggressive tumors and develop …
Still, a small but significant percentage of patients have aggressive tumors and develop …
Linc00941 Is a Novel Transforming Growth Factor β Target That Primes Papillary Thyroid Cancer Metastatic Behavior by Regulating the Expression of Cadherin 6
M Gugnoni, V Manicardi, F Torricelli, E Sauta… - THYROID, 2021 - cris.unibo.it
Background: Papillary thyroid cancers (PTCs) are common, usually indolent malignancies.
Still, a small but significant percentage of patients have aggressive tumors and develop …
Still, a small but significant percentage of patients have aggressive tumors and develop …